RESEARCH TRIANGLE PARK, N.C., April 17, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc., the clinical research industry’s leading MetasiteTM, today announced the launch of a stand-alone Patient Recruitment Solution to deliver patients to sites that are eligible, medically reviewed, and fully consented. While traditional central patient recruitment campaigns have proven to be effective in accelerating enrollment, they are fraught with inefficiencies. The majority of referred patients are not fully qualified, do not have a documented medical history, or are not fully informed regarding expectations for the study. Many sites don’t have adequate resources to follow up on all their referrals, and even when they can, very few patients ever make it to their first screening visit. Sometimes these patient referrals are even offered the ability to participate in competing studies. Science 37 is leveraging its Metasite to not only recruit patients but also to acquire and review the patients’ full medical records and consent the patients into studies with oversight from Science 37 Primary Investigators

Science 37 Holdings, a drug trials services company based in Research Triangle Park, says it laid off 73 employees, or about 23% of its staff, on Thursday.

Decentralized trial company Science 37 to be acquired by eMed in $38M deal.